Module 19 · Renal, fluids & metabolic

Endocrine and metabolic emergencies

NewPhase 1

Recognise and treat the endocrine emergencies seen in Indian ICUs: DKA (including euglycaemic DKA with SGLT2 inhibitors), HHS, adrenal crisis, thyroid storm and myxoedema coma, plus ICU glucose targets and hypoglycaemia.

6 topics

Drugs in this module

Doses written for this module's context. The same drug may read differently in another module.

Regular (soluble) insulin infusion

Insulin

Indications
DKA, HHS, ICU hyperglycaemia, hyperkalaemia.
Adult dose
DKA: fixed rate 0.1 units/kg/h (optional 0.1 units/kg bolus). HHS: 0.05 units/kg/h once glucose stops falling with fluids alone. ICU hyperglycaemia: protocol-driven to 140-180 mg/dL.
Preparation (India)
50 units in 50 mL 0.9% saline (1 unit/mL). Check vial strength: U-40 (40 units/mL) or U-100.
Cautions
Hypokalaemia (do not start if K+ < 3.5 mmol/L), hypoglycaemia, hypophosphataemia.

Hydrocortisone

Glucocorticoid (with mineralocorticoid activity at high dose)

Indications
Adrenal crisis; thyroid storm; myxoedema coma (until adrenal insufficiency excluded); septic shock.
Adult dose
Adrenal crisis: 100 mg IV bolus, then 200 mg/24 h (continuous or 50 mg every 6 h); taper over 1-3 days once stable. Thyroid storm: 300 mg IV load then 100 mg every 8 h.
Preparation (India)
Hydrocortisone sodium succinate 100 mg vials.
Cautions
Hyperglycaemia, hypernatraemia; fludrocortisone not needed while hydrocortisone > 50 mg/day.

Propylthiouracil (PTU)

Thionamide

Indications
Thyroid storm (preferred: also blocks T4→T3 conversion); first-trimester pregnancy.
Adult dose
500-1000 mg loading dose orally/NG, then 250 mg every 4 h.
Cautions
Hepatotoxicity, agranulocytosis. Methimazole 60-80 mg/day is the alternative.

Propranolol

Non-selective β-blocker

Indications
Thyroid storm; thyrotoxic periodic paralysis.
Adult dose
60-80 mg orally/NG every 4 h; IV 1 mg slowly, repeat. Esmolol infusion if unstable or asthma.
Cautions
Thyrotoxic cardiomyopathy with low output: use esmolol cautiously with echo guidance.

Levothyroxine

Thyroid hormone

Indications
Myxoedema coma.
Adult dose
IV 200-400 mcg load, then 1.6 mcg/kg/day (IV dose ≈ 75% of oral); lower doses in elderly/cardiac disease.
Preparation (India)
Tablets (NG) widely available; IV vials limited.
Cautions
Precipitates myocardial ischaemia and arrhythmias; give hydrocortisone first.

Dextrose (glucose)

Carbohydrate

Indications
Hypoglycaemia; with insulin in DKA once glucose < 250 mg/dL; hyperkalaemia.
Adult dose
Hypoglycaemia: 15-25 g IV (e.g. 150-200 mL 10% or 50 mL 25% dextrose / 50 mL 50% via large vein), recheck at 15 min.
Preparation (India)
5%, 10%, 25% (25 mL ampoules) and 50% available.
Cautions
50% is sclerosant: use a large vein and flush.

Potassium chloride

Electrolyte

Indications
Potassium replacement during DKA/HHS treatment.
Adult dose
K+ < 3.5: 10 mmol/h IV before insulin. K+ 3.5-5.0: 20-30 mmol per litre of IV fluid to keep K+ 4-5 mmol/L.
Preparation (India)
15% KCl 10 mL ampoule = 20 mmol; premixed bags preferred.
Cautions
Never as an undiluted bolus; reduce in oliguria.

Sodium bicarbonate

Alkalinising agent

Indications
DKA with pH < 7.0 only.
Adult dose
100 mmol (100 mL 8.4%) in 400 mL sterile water over 2 h; repeat until pH > 7.0.
Cautions
Hypokalaemia, paradoxical CSF acidosis, cerebral oedema risk in children.

Module references (9)

  1. 1

    Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024;47(8):1257-1275

  2. 2

    Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389

  3. 3

    Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421

  4. 4

    Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751

  5. 5

    Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-277

  6. 6

    NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297

  7. 7

    Gunst J, Debaveye Y, Güiza F, et al. Tight blood-glucose control without early parenteral nutrition in the ICU (TGC-fast). N Engl J Med. 2023;389(13):1180-1190

  8. 8

    Honarmand K, Sirimaturos M, Hirshberg EL, et al. Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024. Crit Care Med. 2024;52(4):e161-e181

  9. 9

    American Diabetes Association Professional Practice Committee. 16. Diabetes care in the hospital: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S321-S334